US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Gastrointestinal Market Research Reports & Industry Analysis

RSS Feeds

Gastrointestinal Industry Research & Market Reports

3  4  5  6    8    10  11  12  
Apriso (Ulcerative Colitis) - Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting the UC market ...  |  read more...
USD 3,495
Entyvio (Ulcerative Colitis) - Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting the UC market ...  |  read more...
USD 3,495
Remicade (Ulcerative Colitis) - Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting the UC market ...  |  read more...
USD 3,495
PharmaPoint: Ulcerative Colitis - China Drug Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting the ...  |  read more...
USD 4,995
PharmaPoint: Ulcerative Colitis - India Drug Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting the ...  |  read more...
USD 4,995
PharmaPoint: Ulcerative Colitis - Canada Drug Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting the ...  |  read more...
USD 4,995
PharmaPoint: Ulcerative Colitis - 5EU Drug Forecast and Market Analysis to 2022
2/28/2014 | published by: GlobalData
... & Johnson’s (J&J’s) Simponi and Takeda’s Entyvio, which will lead to an increase in the overall number of patients being treated with biologics in the US, 5EU, Japan, and Canada. Another key event affecting the ...  |  read more...
USD 6,995
2014 U.S. Patient care - Digestive system sold through Offices of physicians-Product & Services Report
4/15/2014 | published by: Barnes Reports
... Barnes Reports, contains timely and accurate industry statistics, forecasts and demographics. The report features 2014 current and 2015 forecast estimates on the sales of Patient care - Digestive system sold through Offices of physicians nationally ...  |  read more...
USD 199
Digestive Remedies in Greece
4/11/2014 | published by: Euromonitor International
... medicines on the so-called negative list of non-reimbursable prescription-only drugs during May 2011 remained the two major negative influences on value sales in digestive remedies during 2013. Shrinking disposable income levels pushed many Greek consumers ...  |  read more...
USD 900
Digestive Remedies in Pakistan
4/10/2014 | published by: Euromonitor International
... of digestive remedies in the country in 2013. This was most obvious among younger adults, who prefer to eat out and late at night. Euromonitor International's Digestive Remedies in Pakistan report offers a comprehensive guide ...  |  read more...
USD 900
Digestive Remedies in Portugal
5/9/2014 | published by: Euromonitor International
... indeed avoid digestion-related discomfort. The prevailing distrust in standard products and the generally gloomy economic environment in Portugal continued to have a negative impact on digestive remedies overall in 2013. However, recently introduced OTC categories ...  |  read more...
USD 900
Digestive Remedies in Ireland
5/12/2014 | published by: Euromonitor International
... with Irish consumers increasingly confident and assured in terms of the self-management of a wide variety of digestive complaints. The advice of pharmacists remains a key element boosting sales in the category, with the high ...  |  read more...
USD 900
Digestive Remedies in the United Kingdom
5/12/2014 | published by: Euromonitor International
... attention to digestive problems, which to some extent contributed to sustaining sales in the category, as people became more aware of digestive issues and looked for remedies when it was not possible to improve the ...  |  read more...
USD 900
Pharmaceuticals: Digestive Remedies in France
6/5/2014 | published by: Euromonitor International
... market for digestive remedies is not affected by scandals or a negative climate – in Belgium, the category pays notably for a scandal about Motilium. In addition, there is limited cannibalisation between PPI and antacids. ...  |  read more...
USD 900
Pharmaceuticals: Digestive Remedies in Thailand
6/3/2014 | published by: Euromonitor International
... Thais tend to cause stress, combined with eating late, which causes increased stomach acid together with digestive disorders that can lead to chronic heartburn symptoms. Work-life balance seemed not to be practical in urban Thai ...  |  read more...
USD 900
Digestive Remedies in Dominican Republic
4/30/2014 | published by: Euromonitor International
... growth in all price-sensitive product offers like generics and private label (measured/tracked) and informal products (not measured/not tracked). Euromonitor International's Digestive Remedies in Dominican Republic report offers a comprehensive guide to the size and shape ...  |  read more...
USD 900
Digestive Remedies in Malaysia
4/30/2014 | published by: Euromonitor International
... As such, many people usually have difficulty digesting their food. Besides, a busier and more hectic lifestyle also contributed to more digestive problems as consumers have quicker meals, eat whilst working or doing something else, ...  |  read more...
USD 900
Digestive Remedies in Mexico
5/1/2014 | published by: Euromonitor International
... the workplace in big cities is often time-consuming and people usually have no time to eat at their homes. In addition, the increasing number of women who joined the workplace resulted in no-one being at ...  |  read more...
USD 900
Digestive Remedies in Singapore
5/2/2014 | published by: Euromonitor International
... of food outside the home, which was less healthy than home-cooked meals. Euromonitor International's Digestive Remedies in Singapore report offers a comprehensive guide to the size and shape of the market at a national level. ...  |  read more...
USD 900
Update: Ulcerative colitis Pipeline Highlights – 2014
5/1/2014 | published by: Fore Pharma
... therapies for Ulcerative colitis in active clinical development stages including early and late stage clinical trials. The pipeline data presented in this report helps executives for tracking competition, identifying partners, evaluating opportunities, formulating business development ...  |  read more...
USD 590
Uruguay Digestive Remedies
6/12/2014 | published by: Euromonitor International
... upper-income young married couples, singles and divorced living alone who do not cook for dinner either. Poor eating habits increase digestive disorders and explain higher demand for indigestion and heartburn remedies. Euromonitor International's Digestive Remedies ...  |  read more...
USD 900
Market Highlights: France Irritable Bowel Syndrome – 2014
5/1/2014 | published by: Fore Pharma
... forecast in France. The research includes France irritable bowel syndrome market size estimates for 2013, market share forecast for six years to 2019, irritable bowel syndrome drugs market share, irritable bowel syndrome drugs sales estimates, ...  |  read more...
USD 990
Market Highlights: Italy Irritable Bowel Syndrome – 2014
5/1/2014 | published by: Fore Pharma
... forecast in Italy. The research includes Italy irritable bowel syndrome market size estimates for 2013, market share forecast for six years to 2019, irritable bowel syndrome drugs market share, irritable bowel syndrome drugs sales estimates, ...  |  read more...
USD 990
Market Highlights: US Irritable Bowel Syndrome – 2014
5/1/2014 | published by: Fore Pharma
... sales forecast in the US. The research includes the US irritable bowel syndrome market size estimates for 2013, market share forecast for six years to 2019, irritable bowel syndrome drugs market share, irritable bowel syndrome ...  |  read more...
USD 990
Market Highlights: Europe Irritable Bowel Syndrome – 2014
5/1/2014 | published by: Fore Pharma
... for Germany, France, Italy, Spain, and UK. The research includes Europe (Germany, France, Italy, Spain, and UK) irritable bowel syndrome market size estimates for 2013, market share forecast for six years to 2019, irritable bowel ...  |  read more...
USD 2,800
3  4  5  6    8    10  11  12